Replies to post #2799 on Lifeline Biotech ( LLBT LLBO)

[NikkiBaker]

Penny, I own 22mil shares here, and I think this is due for a run to .001+, BUT...this company has dumped BILLIONS into the float in recent months. IF they had money, there would be no need to sell billions of shares. So, I always question such information/rumors. I don't believe they are going to buyback anything. Rooter mentioned nothing of that to me. INFACT, rooter wrote to me and said they might actually sell some here. I can send you his pm to me if you'd like.

[uwlungman]

pennystock. Here is the earnings pr from Nov. 2006...
Lifeline Biotechnologies, Inc. Reports Over $2 Million Profit -- as Featured on MacReport.Net

RENO, NV--(MARKET WIRE)--Nov 7, 2006 -- Lifeline Biotechnologies, Inc. (www.lbtn.com) (Other OTC:LBTN.PKNews) today announced that Jim Holmes, CEO and President of Lifeline Biotechnologies, Inc., was featured on MacReport.Net. In his interview, Mr. Holmes discussed the recent developments with the Company and the posted quarterly financial statements on www.lbti.com showing over $2 million in revenues.

Lifeline Biotechnologies, Inc. has partial ownership of Solos Endoscopy and is going to continue to assist in the development of the First Warning System. Mr. Holmes discussed that Solos Endoscopy has a long history in the medical field and has the necessary tools available to produce the First Warning System once it is ready to be released on the market.

"We are very pleased with the results from the recent sale of our medical technology to Solos Endoscopy and acquired interest in Trendsetter Solar Products. The previous twelve years, we have been a research and development company and are concentrating on acquiring additional medical products with existing sales. We look forward to an encouraging and successful future with additional acquisitions," stated Jim Holmes, CEO of Lifeline Biotechnologies, Inc.

Lifeline Biotechnologies, Inc. recently announced that the Company has reported operating profits of $2,012,098 for the first three quarters of 2006. Lifeline Biotechnologies' unaudited financial statements also show revenues of $2.7 Million, which were generated by the sale of Lifeline's medical products to Solos Endoscopy and other operating sources.

To listen to the interview in its entirety, please visit: www.MacReport.net.

About Lifeline Biotechnologies, Inc.:

Lifeline Biotechnologies develops and acquires undervalued companies which have innovative technology in the medical, nutraceutical, and energy industries, to increase the growth of the Company. Lifeline Biotechnologies continues to seek out and capitalize on emerging technologies that will change the medical, nutraceutical, and energy community. More information is available at the company's website: www.lbtn.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


Contact:
Contact: Lifeline Biotechnologies, Inc. Investor Relations 407-884-0444 or 1-866-THE-APPLE